Evaluate the Effects of Repeated Periods of Modified Fasting to Support Healthy Natural Weight Management and Prevention of Weight Gain

Inclusion Criteria: * Ambulatory, male or female, 21-65 years of age * A body mass index (BMI) of 23-34.9 * Generally healthy and having no significant difficulty with digestion of food * Has been generally weight stable for the past six months * Willing to discontinue use of any (non-study) multivitamin or Vitamin D supplements during the study * Willing and able to give written informed consent * Clearly understands the procedures and study requirements * Willing and able to comply with all study procedures, including following the recommendations to maintain their usual diet and regular activity, as per protocol * Able to communicate, including reading, in English Primary Exclusion Criteria: * Having smoked any cigarette, electronic cigarette, cigar, pipe, or used a recreational drug in the past 30 days * History of allergy or sensitivity to any component of the study products including milk, soy and almonds * Donation of blood with 30 days prior to screening/baseline * Inability to provide a venous blood sample * Participation in another study within 30 days prior to baseline/screening * Being pregnant or planning on becoming pregnant during study participation; or breast feeding * Having been diagnosed, received medical treatment or taking medication daily for the following medical condition(s): * Diabetes mellitus * Eating disorder * Acute or chronic inflammatory disease or autoimmune disease * Cardiovascular disease * Gastrointestinal disease including gallbladder problems, gallstones or biliary tract obstruction * Thyroid disease (unless on a stable dose of medication for 3 months prior to screening and unlikely to change medication or dose during the study) * Hypertension (unless on a stable dose of medication for 3 months prior to screening and unlikely to change medication or dose during the study) * Psychiatric disorder * Neurologic condition/disease * Cancer (unless skin cancer other than melanoma which has been treated \> 3 years prior to Baseline/screening) * Active or chronic liver, pancreatic and kidney disease * Blood coagulation disorder * Other condition or medication use that would preclude participation in the study in the judgment of the investigator/sub-investigator (Sub-I) * Currently taking or having taken within the 30 days prior to screening/baseline any hormone replacement therapy (including DHEA (dehydroepiandrosterone), estrogen, progesterone, or testosterone; except those utilized as a method of birth control and which have been taken for \> 3 months, with no anticipated change for the duration of the study) * Currently taking any of the nutritional supplements used in the study and unwilling to discontinue use at least 14 days prior to screening. * Currently taking a medication or nutritional supplement specifically for weight loss and unwilling to discontinue use 14 days prior to the first dosing of study supplements * Currently participating in a weight loss program and unwilling to discontinue participation prior to enrollment into the study * Currently taking an anti-coagulant, anti-platelet medication or a glucose lowering medication * Having had a surgical procedure or having an internal medical device which, in the judgment of the PI/Sub-I, would preclude participation in the study * Having abnormal screening laboratory test values including bilirubin \> 2.5 x ULN (upper limit of normal), AST/SGOT(aspartate aminotransferase/serum glutamin oxaloacetic transaminase) and ALT/SGPT (alanine aminotransferase/serum glutamic pyruvic transaminase) \> 2.5 x ULN, serum creatinine \> 1.5 mg/dL, blood glucose \< 85 mg/dL or \> 125 mg/dL, and TSH(thyroid stimulating hormone) \> 4.12 µIU/mL, or other lab test result(s) that would preclude study participation in the judgement of the PI/Sub-I * Having blood pressure readings at Baseline/screening \> 140 systolic or \> 90 diastolic on two consecutive readings unless permitted to proceed to the next visit in the judgment of the PI/Sub-I * Currently consumes more than 7 standard alcoholic drinks per week for women and 14 drinks per week for men (a standard alcoholic drink is defined as one bottle/can of beer, one glass of wine, or one ounce of hard liquor) * Unable or unwilling to avoid consuming grapefruit juice or fresh grapefruit, Seville oranges and tangelos * Having any other circumstance that precludes study participation in the judgment of the PI/Sub-I including use of other nutritional supplements which will be evaluated on a case-by-case basis.